These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6154055)

  • 21. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanical deformation of polymer matrix controlled release devices modulates drug release.
    Edelman ER; Fiorino A; Grodzinsky A; Langer R
    J Biomed Mater Res; 1992 Dec; 26(12):1619-31. PubMed ID: 1484066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(alkylcyanoacrylate) colloidal particles as vehicles for antitumour drug delivery: a comparative study.
    Arias JL; Ruiz MA; López-Viota M; Delgado AV
    Colloids Surf B Biointerfaces; 2008 Mar; 62(1):64-70. PubMed ID: 17961994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Encapsulation efficiency and controlled release characteristics of crosslinked polyacrylamide particles.
    Sairam M; Babu VR; Vijaya B; Naidu K; Aminabhavi TM
    Int J Pharm; 2006 Aug; 320(1-2):131-6. PubMed ID: 16766148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme immobilization by radiation-induced polymerization of 2-hydroxyethyl methacrylate at low temperatures.
    Kaetsu I; Kumakura M; Yoshida M
    Biotechnol Bioeng; 1979 May; 21(5):847-61. PubMed ID: 107982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled drug dissolution by radiation-induced polymerization in the presence of dimethylaminoethyl methacrylate-methyl methacrylate copolymer or methacrylic acid-methyl acrylate copolymer.
    Yoshida M; Kumakura M; Kaetsu I
    J Pharm Sci; 1979 Jul; 68(7):860-2. PubMed ID: 458603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled release of furosemide from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Shin SC
    Int J Pharm; 2005 Aug; 299(1-2):127-33. PubMed ID: 15967605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on hormone-polymer composites in urological field--their application in prostatic cancer therapy].
    Yamanaka H
    Hinyokika Kiyo; 1983 Dec; 29(12):1579-86. PubMed ID: 6375311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymers for the controlled release of macromolecules: effect of molecular weight of ethylene-vinyl acetate copolymer.
    Hsu TT; Langer R
    J Biomed Mater Res; 1985 Apr; 19(4):445-60. PubMed ID: 4055827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of hydrophobe on the release behavior of vinyl acetate miniemulsion polymerization.
    Park SJ; Kim KS
    Colloids Surf B Biointerfaces; 2005 Nov; 46(1):52-6. PubMed ID: 16214307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP.
    Dashevsky A; Kolter K; Bodmeier R
    Eur J Pharm Biopharm; 2004 Jul; 58(1):45-9. PubMed ID: 15207536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microporous structure and drug release kinetics of polymeric nanoparticles.
    Sant S; Thommes M; Hildgen P
    Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
    Asghar LF; Azeemuddin M; Jain V; Chandran S
    Drug Deliv; 2009 May; 16(4):205-13. PubMed ID: 19514981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting release rate of diltiazem hydrochloride from poly (2-hydroxyethyl methacrylate) matrices.
    Yanagawa F; Ishii Y; Onuki Y; Morishita M; Takayama K
    Colloids Surf B Biointerfaces; 2008 May; 63(1):146-52. PubMed ID: 18242964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel hydrogel membrane based on copoly(hydroxyethyl methacrylate/p-vinylbenzyl-poly(ethylene oxide)) for biomedical applications: properties and drug release characteristics.
    Arica MY; Bayramoglu G; Arica B; Yalçin E; Ito K; Yagci Y
    Macromol Biosci; 2005 Oct; 5(10):983-92. PubMed ID: 16208632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular evaluation of oral chemotherapy carriers.
    Blanchette J; Peppas NA
    J Biomed Mater Res A; 2005 Mar; 72(4):381-8. PubMed ID: 15666363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicochemical Characteristics and Slow Release Performances of Chlorpyrifos Encapsulated by Poly(butyl acrylate-co-styrene) with the Cross-Linker Ethylene Glycol Dimethacrylate.
    Wang Y; Gao Z; Shen F; Li Y; Zhang S; Ren X; Hu S
    J Agric Food Chem; 2015 Jun; 63(21):5196-204. PubMed ID: 25946639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous polymeric matrix system poly(HEMA-BGA) for controlled release of an anticancer drug (5-fluorouracil). I. Synthesis and structure.
    Denizli A; Kiremitçi M; Pişkin E
    Biomaterials; 1988 May; 9(3):257-62. PubMed ID: 3408798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.